Study of DONQ52 in Active Celiac Disease
for Celiac Disease
Drug: DONQ52
49 locations incl. Anniston
Sponsor: Chugai Pharmaceutical
Sex: All·Age: 18 - 75
Code: NCT07239336·Phase 2·Recruiting
Celiac disease Clinical Trials in Las Vegas, NV
As of June 2026, 1 paid clinical trial is recruiting for Celiac disease in Las Vegas, Nevada. Recruiting Celiac disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Las Vegas
Filter results
Filter results
1 clinical trial for Celiac disease
·Clear filters·↓ Download CSVAbout research studies in Las Vegas
Las Vegas has approximately 428 recruiting research studies across a wide range of therapeutic areas. Nevada hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Top Research Study Locations in Las Vegas
Researchers run research studies in Las Vegas, NV at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Comprehensive Cancer Centers of Nevada | Breast Cancer, Malignant Solid Neoplasm, Gastroesophageal Junction Adenocarcinoma | 53 |
| OptumCare Cancer Care at Charleston | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 52 |
| OptumCare Cancer Care at Fort Apache | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Anatomic Stage II Breast Cancer AJCC v8 | 51 |
| Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Anatomic Stage IV Breast Cancer AJCC v8 | 49 |
| Summerlin Hospital Medical Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Anatomic Stage IV Breast Cancer AJCC v8 | 46 |
| University Medical Center of Southern Nevada | Malignant Solid Neoplasm, Acute Myeloid Leukemia, Anatomic Stage IV Breast Cancer AJCC v8 | 41 |
| Sunrise Hospital and Medical Center | Malignant Solid Neoplasm, Recurrent B Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 38 |
| Comprehensive Cancer Centers of Nevada - Central Valley | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 34 |
| Comprehensive Cancer Centers of Nevada - Northwest | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 31 |
| Comprehensive Cancer Centers of Nevada - Town Center | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 31 |
| Comprehensive Cancer Centers of Nevada-Summerlin | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 31 |
| OptumCare Cancer Care at MountainView | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 31 |
| Radiation Oncology Centers of Nevada Central | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer | 31 |
| Hope Cancer Care of Nevada | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 30 |
| Radiation Oncology Centers of Nevada Southeast | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Breast Cancer | 30 |
| Ann M Wierman MD LTD | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 28 |
| Las Vegas Urology - Cathedral Rock | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 28 |
| Las Vegas Urology - Pecos | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 28 |
| Las Vegas Urology - Smoke Ranch | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 28 |
| Urology Specialists of Nevada - Northwest | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 28 |
| Urology Specialists of Nevada - Southwest | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 28 |
| Las Vegas Urology - Sunset | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 27 |
| Urology Specialists of Nevada - Central | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 27 |
| University Cancer Center | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 26 |
| Las Vegas Prostate Cancer Center | Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Melanoma | 25 |
Active & Upcoming Studies in Las Vegas (2026)
Recruiting trials in Las Vegas grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (113 active studies)
- A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer · Phase 3 · J-Pharma Co., Ltd.
- ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL · Phase 3 · Newave Pharmaceutical Inc
Neurology & pain (33 active studies)
- An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD) · Phase 2 · Yale University
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Diabetes & metabolic (32 active studies)
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus · Phase 2 · Hanmi Pharmaceutical Company Limited
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Mental health & behavior (14 active studies)
- 52-week Open Label Safety-Tolerability Study · Phase 3 · LB Pharmaceuticals Inc.
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
Cardiovascular (12 active studies)
Eye & vision (5 active studies)
- Investigator Initiated Trial Using Dry Eye Surveys to Evaluate and Better Understand FDA Approved Acoltremon Treatment for Dry Eye Disease in Real World Treatment Settings (DESERT) · Phase 4 · Center for Sight Las Vegas
- 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study · Iantrek, Inc.
Vaccines (4 active studies)
- A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. · Phase 1 · ModeX Therapeutics, An OPKO Health Company
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
HIV / STI (3 active studies)
- REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE · Phase 4 · CAN Community Health
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of VH4011499 Compared to Placebo in Adults Without HIV · Phase 1 · ViiV Healthcare
Common conditions studied in Las Vegas
- Obesity (11 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Major Depressive Disorder (10 active studies). Major depressive disorder research examines rapid-acting agents, augmentation strategies, and digital therapeutics for treatment-resistant cases.
- Acute Myeloid Leukemia (8 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Alzheimer Disease (8 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Overweight (8 active studies). Recruiting Overweight studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Malignant Solid Neoplasm (7 active studies). Recruiting Malignant Solid Neoplasm studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Las Vegas
- National Cancer Institute (NCI)
- Eli Lilly and Company
- University of Nevada, Las Vegas
- Children's Oncology Group
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in Nevada are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Nevada research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Las Vegas. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Las Vegas
Hipa.ai aggregates every recruiting study in Las Vegas from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Las Vegas?
There are approximately 428 recruiting clinical trials in Las Vegas, Nevada listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Las Vegas pay participants?
Most recruiting trials in Las Vegas compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Las Vegas?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Las Vegas?
The most common conditions under active study in Las Vegas include Obesity (11), Major Depressive Disorder (10), Acute Myeloid Leukemia (8), Alzheimer Disease (8), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Las Vegas?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Las Vegas on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Las Vegas?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Las Vegas?
Recruiting research sites in Las Vegas include Comprehensive Cancer Centers of Nevada, OptumCare Cancer Care at Charleston, OptumCare Cancer Care at Fort Apache, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Las Vegas right now?
The largest active categories in Las Vegas are Cancer & tumors (113), Neurology & pain (33), Diabetes & metabolic (32). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.